← Eichor
Study identifier: NCT06296979 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Noninvasive Phrenic Nerve Neuromodulation in Shoulder Pain and Hepatobiliary Visceral Comorbidity.

Condition: Shoulder Pain  ·  Sponsor: University of Seville

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Pain, particularly shoulder pain, is a social and economic problem worldwide. Although visceral pathology is not yet taken into account in the diagnosis of these pains, it is likely that on numerous occasions the hepatobiliary visceral condition causes referred pain in the metameric area belonging to the shoulder due to the involvement of the phrenic nerve. Therefore, the aim of this project is to study the response of treatment by neuromodulation of the phrenic nerve for shoulder pain in patients with associated hepatobiliary pathologies, assessing the possible visceral involvement in the symptomatology.

This description comes directly from the study's public registry record.

Talk to the study team

Adolfo Rosado Portillo  ·  605663879  ·  adolforosadoportillo@gmail.com

Always discuss trial participation with your own doctor first.

Locations (4)

Centro de Salud Ronda HistóricaSeville, Sevilla, SpainRecruiting
Centro de Salud las LetaníasSeville, Sevilla, SpainRecruiting
Centro de Salud BellavistaSeville, sevilla, SpainRecruiting
Centro de especialidades Morón de la FronteraMorón de la Frontera, Seville, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06296979